Celularity Inc. Receives Nasdaq Notice Regarding Minimum Market Value Deficiency

On June 9, 2026, Celularity Inc. received a written notice from the Nasdaq Stock Market LLC indicating that the company is no longer in compliance with the minimum Market Value of Listed Securities (MVLS) requirement. Specifically, the company's MVLS fell below the $35 million threshold required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) for 30 consecutive business days. Nasdaq has granted Celularity a 180-day grace period, expiring on December 7, 2026, to regain compliance. To achieve this, the company's market value must meet or exceed $35 million for at least 10 consecutive business days. Alternatively, the company may explore other compliance options, such as increasing stockholders' equity to at least $2.5 million. The notice does not currently impact the listing of Celularity’s common stock or warrants, but failure to regain compliance by the deadline could result in delisting, subject to an appeals process.